| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
MaxCyte Inc (OTCGREY: MAXC)
MAXC Technical Analysis
5
| As on 16th Dec 2021 MAXC SHARE Price closed @ 1.78 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 5.02 & Strong Sell for SHORT-TERM with Stoploss of 2.20 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MAXCSHARE Price
| Open | 1.78 | Change | Price | % |
| High | 1.88 | 1 Day | 0.00 | 0.00 |
| Low | 1.77 | 1 Week | -0.04 | -2.20 |
| Close | 1.78 | 1 Month | -0.29 | -14.01 |
| Volume | 350610 | 1 Year | 0.15 | 9.20 |
| 52 Week High 17.00 | 52 Week Low 0.89 | ||||
OTCGREY USA Most Active Stocks
| ISVQF | 5.45 | 0.18% |
| IARED | 24.62 | % |
| BLBRF | 0.11 | % |
| JRVMF | 0.05 | 0.00% |
| GCEA | 29.00 | -21.20% |
| AHLD | 82.75 | -2.93% |
| MAXC | 1.78 | 0.00% |
| MNSLV | 25.50 | 1.03% |
| PCOFF | 0.16 | % |
| EHITF | 613.00 | -98.77% |
OTCGREY USA Top Gainers Stocks
OTCGREY USA Top Losers Stocks
| MAXC Daily Charts |
MAXC Intraday Charts |
Whats New @ Bazaartrend |
MAXC Free Analysis |
|
|
MAXC Important Levels Intraday
| RESISTANCE | 1.99 |
| RESISTANCE | 1.92 |
| RESISTANCE | 1.88 |
| RESISTANCE | 1.84 |
| SUPPORT | 1.72 |
| SUPPORT | 1.68 |
| SUPPORT | 1.64 |
| SUPPORT | 1.57 |
MAXC Forecast April 2024
| 4th UP Forecast | 1.78 |
| 3rd UP Forecast | 1.78 |
| 2nd UP Forecast | 1.78 |
| 1st UP Forecast | 1.78 |
| 1st DOWN Forecast | 1.78 |
| 2nd DOWN Forecast | 1.78 |
| 3rd DOWN Forecast | 1.78 |
| 4th DOWN Forecast | 1.78 |
MAXC Weekly Forecast
| 4th UP Forecast | 1.78 |
| 3rd UP Forecast | 1.78 |
| 2nd UP Forecast | 1.78 |
| 1st UP Forecast | 1.78 |
| 1st DOWN Forecast | 1.78 |
| 2nd DOWN Forecast | 1.78 |
| 3rd DOWN Forecast | 1.78 |
| 4th DOWN Forecast | 1.78 |
MAXC Forecast2024
| 4th UP Forecast | 33.67 |
| 3rd UP Forecast | 23.44 |
| 2nd UP Forecast | 17.12 |
| 1st UP Forecast | 10.8 |
| 1st DOWN Forecast | -7.24 |
| 2nd DOWN Forecast | -13.56 |
| 3rd DOWN Forecast | -19.88 |
| 4th DOWN Forecast | -30.11 |
MaxCyte Inc ( OTCGREY USA Symbol : MAXC )
Sector : N/A And Other Stocks in Same Sector
Sector : N/A And Other Stocks in Same Sector
MAXC Business Profile
MaxCyte, Inc. operates as a cell-based therapies and life sciences company in the United States and internationally. Its transfection systems include MaxCyte STX, a scalable transfection system that uses flow electroporation technology for the engineering of cells for a range of applications; MaxCyte VLX, an instrument for large volume cell-engineering; and MaxCyte GT, a non-viral cell-engineering technology designed for clinical use. The company also provides single use sterile processing assemblies; and proprietary electroporation buffers; and ExPERT brand series of instruments and consumables, as well as insourcing services. In addition, it develops CARMA, a novel and proprietary technology for the development of non-viral, human messenger RNA-based, chimeric antigen receptor or T-cell receptor redirected immune cell therapies. The company licenses and sells its instruments and technology; and sells its products to drug developers and biopharmaceutical companies. It has a clinical and commercial license agreement with Allogene Therapeutics, Inc. The company was founded in 1998 and is headquartered in Gaithersburg, Maryland. Address: 22 Firstfield Road, Gaithersburg, MD, United States, 20878
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service